Gildan Activewear insider plans Rule 144 sale of 1,189 shares

Gildan Activewear Inc. insider plans a small share sale under Rule 144.

Accepted by SEC EDGAR 12/03/2025 - 08:31 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Gildan Activewear Inc. insider plans a small share sale under Rule 144. A holder intends to sell 1,189 shares of Gildan common stock through broker Solium Capital ULC on or around 12/03/2025 on the NYSE, with an aggregate market value of $94,950.59. The filing notes that 151,200,128 shares of Gildan common stock were outstanding. These shares were acquired on 11/20/2025 through vesting of deferral awards, with no cash payment since they were received via equity vesting.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002059304
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Gildan Activewear Inc.
SEC File Number	001-14830
Address of Issuer	600 BOULEVARD DE MAISONNEUVE OUEST 33RD FLOOR MONTREAL QUEBEC, CANADA H3A 3J2
Phone	5147352023
Name of Person for Whose Account the Securities are To Be Sold	John Maness
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Solium Capital ULC Suite 1500 600 3rd Avenue SW Calgary A0 T2P 0G5	1189	94950.59	151200128	12/03/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/20/2025	Vesting in shares of Deferral awards	Gildan Activewear Inc.			1189	11/20/2025	No payment since acquired through vesting of shares.

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	Date of Payment: No payment date since acquired through vesting of shares
Date of Notice	12/03/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ John Maness
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)